Growth Metrics

Insulet (PODD) Capital Expenditures (2016 - 2026)

Insulet filings provide 16 years of Capital Expenditures readings, the most recent being -$37.3 million for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 40.03% to -$37.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $19.2 million, a 110.99% increase, with the full-year FY2025 number at $19.2 million, up 110.99% from a year prior.
  • Capital Expenditures hit -$37.3 million in Q4 2025 for Insulet, down from $52.0 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $112.5 million in Q4 2022 to a low of -$62.2 million in Q4 2024.
  • Median Capital Expenditures over the past 5 years was $3.8 million (2021), compared with a mean of $13.6 million.
  • Biggest five-year swings in Capital Expenditures: tumbled 626.67% in 2022 and later surged 412.66% in 2023.
  • Insulet's Capital Expenditures stood at $108.7 million in 2021, then grew by 3.5% to $112.5 million in 2022, then tumbled by 133.6% to -$37.8 million in 2023, then crashed by 64.55% to -$62.2 million in 2024, then surged by 40.03% to -$37.3 million in 2025.
  • The last three reported values for Capital Expenditures were -$37.3 million (Q4 2025), $52.0 million (Q3 2025), and $1.0 million (Q2 2025) per Business Quant data.